VA Puget Sound Health Care System Seattle Division, Seattle, WA
Welcome,         Profile    Billing    Logout  
 117 Trials 
252 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fortney, John C
CHAMP, NCT04600414: Collaborating to Heal Addiction and Mental Health in Primary Care

Completed
N/A
254
US
Collaborative Care for Mental Health Disorders, Collaborative Care for Opioid Use Disorder
University of Washington, National Institute of Mental Health (NIMH), University of Arkansas, Kaiser Permanente
Opioid-use Disorder, Mental Health Disorder
02/24
08/24
NCT05974631: Evaluating Treatments for Suicidal Veterans With PTSD

Recruiting
N/A
200
US
Dialectical Behavior Therapy, DBT, Dialectical Behavior Therapy Prolonged Exposure protocol, DBT PE, Prolonged Exposure therapy, PE, Suicide risk management, SRM
VA Office of Research and Development
Self-directed Violence, Post-traumatic Stress Disorder (PTSD)
04/27
07/27
Raskind, Murray
NCT02965027: Prazosin for Post-Concussive Headaches

Completed
4
89
US
Prazosin, Minipress, Placebo, inactive substance, sugar pill
Seattle Institute for Biomedical and Clinical Research, VA Puget Sound Health Care System, Madigan Army Medical Center
Post-Traumatic Headache
05/23
06/23
PoND, NCT03221751: Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)

Terminated
4
9
US
prazosin hydrochloride, Minipress, placebo, inactive drug, sugar pill
VA Office of Research and Development
Dementia
01/23
12/23
IMPACT, NCT05776056: Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

Recruiting
4
70
US
Methylphenidate, Ritalin, Placebo
VA Office of Research and Development
Posttraumatic Stress Disorder (PTSD)
07/26
03/27
Peskind, Elaine
NCT02965027: Prazosin for Post-Concussive Headaches

Completed
4
89
US
Prazosin, Minipress, Placebo, inactive substance, sugar pill
Seattle Institute for Biomedical and Clinical Research, VA Puget Sound Health Care System, Madigan Army Medical Center
Post-Traumatic Headache
05/23
06/23
NCT05351801: Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain

Recruiting
2
320
US
THC (Syndros), CBD (Epidolex), THC + CBD (Nabiximols), Placebo
VA Office of Research and Development
Diabetic Neuropathic Pain, Peripheral Neuropathic Pain
06/27
06/27
TRC-PAD, NCT04004767: Program: In-Clinic Trial-Ready Cohort

Completed
N/A
220
US
University of Southern California, National Institute on Aging (NIA), Alzheimer's Therapeutic Research Institute, Alzheimer's Clinical Trials Consortium, Brigham and Women's Hospital, Cleveland Clinic Lou Ruvo Center for Brain Health
Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease, Alzheimer Disease, Dementia
04/24
04/24
Montgomery, Robert B
DASL-HiCaP, NCT04136353: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Active, not recruiting
3
1100
Europe, Canada, US, RoW
Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog, External Beam Radiotherapy
University of Sydney, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Bayer, Cancer Trials Ireland, Canadian Cancer Trials Group, Memorial Sloan Kettering Cancer Center, Prostate Cancer Clinical Trials Consortium
Prostate Cancer
01/28
07/28
BRACeD, NCT04038502: Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Recruiting
2
100
US
Carboplatin, Paraplatin, Olaparib, Lynparza
VA Office of Research and Development
Metastatic Castrate Resistant Prostate Cancer, BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, RAD51B, RAD51C, RAD51D, or RAD54L Mutations
08/25
08/25
VA-BAT, NCT05011383: High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Recruiting
2
51
US
High dose testosterone, Bipolar androgen therapy
VA Office of Research and Development
Metastatic Prostate Cancer
08/26
08/27
SNARE, NCT05593497: A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Recruiting
2
30
US
Capivasertib, abiraterone acetate
VA Office of Research and Development
High-Risk Prostate Cancer
05/27
08/27
CaRe, NCT06056791: Study of INKmune in Patients With mCRPC ( Prostate)

Recruiting
1/2
30
US
INKmune
Inmune Bio, Inc.
Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC
05/25
11/25
OSPREY-AHF, NCT04334668: Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure

Active, not recruiting
N/A
67
US
Oral Sodium Chloride, Placebo
The Cleveland Clinic
Volume Overload
06/22
06/25
NCI-2014-01087, NCT01050504: Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Recruiting
N/A
1500
US
Cytology Specimen Collection Procedure, Cytologic Sampling, Laboratory Biomarker Analysis
University of Washington, National Cancer Institute (NCI)
Localized Renal Pelvis and Ureter Urothelial Carcinoma, Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Recurrent Bladder Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Pelvis and Ureter Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v7, Stage IV Bladder Urothelial Carcinoma AJCC v7, Stage IV Prostate Cancer AJCC v7
01/29
01/29
Smith, Nicholas
EPIC3, NCT05764083: Epidemiology, Immunology and Clinical Characteristics of COVID-19

Completed
N/A
2824
US
VA Office of Research and Development
SARS-CoV-2, COVID-19
09/24
09/24
Au, David H
RELIEF Pilot, NCT04854967: Pilot Study: Post-Recovery LibEration From Oxygen in Exacerbated COPD

Withdrawn
N/A
48
US
Rescind home oxygen order, De-implement oxygen order, Provider Education, Patient Education, Teach-to-goal inhaler training, TTG, Pursed lip breathing
VA Office of Research and Development
Pulmonary Disease, Chronic Obstructive
05/23
05/23
ACHIEVE, NCT03856879: High-quality COPD Care for People with Immune Dysfunction Through Proactive E-consults

Active, not recruiting
N/A
270
US
Proactive E-consult
Seattle Institute for Biomedical and Clinical Research, VA Puget Sound Health Care System, Washington D.C. Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, University of Colorado, Denver, VA Greater Los Angeles Healthcare System, Atlanta VA Medical Center, Yale University, VA Connecticut Healthcare System, Corporal Michael J. Crescenz VA Medical Center, Nashville VA Medical Center
COPD, HIV/AIDS
03/25
04/25
NCT04543461: American Lung Association (ALA) Lung Health Cohort

Recruiting
N/A
4000
US
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), American Lung Association, Stanford University
Lung Diseases
09/26
09/26
EQuiP COPD, NCT05718102: Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Recruiting
N/A
4000
US
Population-health management
Seattle Institute for Biomedical and Clinical Research, Patient-Centered Outcomes Research Institute
Pulmonary Disease, Chronic Obstructive
01/27
01/27
Davis, Lori Lynne
VA-BRAVE, NCT04375033: A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

Recruiting
4
952
US
Sublingual buprenorphine with naloxone, Injectable subcutaneous buprenorphine
VA Office of Research and Development
Opioid Use Disorder
09/28
05/29
NCT04961190: A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD

Recruiting
4
300
US
Prolonged Exposure Therapy, Pharmacotherapy with paroxetine or venlafaxine XR, Pharmacotherapy with Paxil or Effexor XR
University of Pennsylvania, Patient-Centered Outcomes Research Institute, Corporal Michael J. Crescenz VA Medical Center, Coatesville VA Medical Center, Milwaukee VA Medical Center, North Texas Veterans Healthcare System, San Diego Veterans Healthcare System, VA Palo Alto Health Care System, Birmingham VA Health Care System
Posttraumatic Stress Disorder
07/26
07/26
IMPACT, NCT05776056: Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

Recruiting
4
70
US
Methylphenidate, Ritalin, Placebo
VA Office of Research and Development
Posttraumatic Stress Disorder (PTSD)
07/26
03/27
VAST-D II, NCT05554627: VA Aripiprazole vs Esketamine for Treatment Resistant Depression

Withdrawn
4
940
US
Esketamine, Spravato (for depression), Ketanest (for anesthesia), Aripiprazole, Abilify, Aristada
VA Office of Research and Development
Depressive Disorder, Major
10/23
10/23
NCT03852628: Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

Terminated
2
69
US
2mg Buprenex and 380mg Vivitrol, 2mg Buprenex (SL, qd) and 380mg Vivitrol (IM, q4weeks), 2mg BUP/NLTRX, Placebo (SL pill qd, IM injection q4weeks), Placebo
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, United States Department of Defense, RTI International
Post Traumatic Stress Disorder, Alcohol Abuse
05/22
01/23
VocRehab, NCT00260507: The Impact of Vocational Rehabilitation for Mentally Ill Veterans

Active, not recruiting
N/A
100
US
Standard Vocational Rehabilitation, VRP, Supportive Employment, SE
Tuscaloosa Research & Education Advancement Corporation
PTSD
06/10
05/14
Pan-ACT, NCT05433662: Telehealth Acceptance and Commitment Therapy for Older Veterans Experiencing Pandemic-Related Stress

Completed
N/A
24
US
Pandemic Acceptance and Commitment Therapy (Pan-ACT), Acceptance and Commitment Therapy (ACT); ACT for Older Adults; The Third ACT
VA Office of Research and Development, University of Alabama, Tuscaloosa
Psychological Stress
12/24
01/25
MiMP, NCT05363371: Minds and Mentors Program- R33

Recruiting
N/A
240
US
Minds and Mentors, Twelve Step Intervention Group
University of Alabama, Tuscaloosa, University of Alabama at Birmingham, Tuscaloosa Veterans Affairs Medical Center, Pathway Healthcare, LLC
Opioid Use Disorder, Substance Use Disorders, Medication Assisted Treatment
08/24
08/24
NCT06770998: A Study of a Novel EEG Neurofeedback System for PTSD Treatment

Not yet recruiting
N/A
250
US
EEG-neurofeedback training, Prism training, amyg-EFP training, active Prism training, Sham training, sham Prism training
Foundation for Atlanta Veterans Education and Research, Inc., GrayMatters Health Ltd., Rochester Institute of Technology, New York University Grossman School of Medicine, Atlanta VA Medical Center, Birmingham VA Health Care System, Ralph H. Johnson VA Medical Center, VA Boston Healthcare System, CTP Inc, BioStats Statistical Consulting Ltd, ShareCRF, United States Department of Defense
Stress Disorders, Post-Traumatic
06/27
08/27
THRIVE, NCT05388812: Together in Recovery With Veterans Through Employment

Recruiting
N/A
120
US
Treatment As Usual Vocational Rehabilitation (TAU-VR), Individual Placement and Support (IPS)
VA Office of Research and Development
Veterans With Opioid Use Disorder
08/26
09/26
Klute, Glenn K
NCT03900845: Adherence and Perspiration While Wearing Lower Limb Prostheses

Active, not recruiting
N/A
25
US
Dynamic Air Exchange - Rising Edge Design (DAE-RED), Perforated elastomeric liner, Uniprox Softskin Air prosthesis liner, As-prescribed prosthesis
Seattle Institute for Biomedical and Clinical Research, United States Department of Defense
Lower Extremity Amputation
04/22
04/25
NCT03532100: Pivot-Flex Foot: Optimal Coupling Ratio Between Transverse and Sagittal-plane Motions Using a Torsionally Adaptive Prosthesis for Individuals With Lower Limb Amputation

Recruiting
N/A
15
US
Torsionally adaptive prosthesis with 0:1 coupling ratio, Torsionally adaptive prosthesis with 1:6 coupling ratio, Torsionally adaptive prosthesis with 1:4 coupling ratio, Torsionally adaptive prosthesis with 1:3 coupling ratio, Torsionally adaptive prosthesis with 1:2 coupling ratio
VA Office of Research and Development
Lower Extremity Amputation
10/24
03/25
ABC, NCT06711588: Automatic Prosthetic Foot Stiffness Modulation to Improve Balance

Not yet recruiting
N/A
20
US
As-prescribed stiffness, Two categories stiffer than the as-prescribed stiffness, Two categories less stiff than the as-prescribed stiffness
Seattle Institute for Biomedical and Clinical Research
Lower Limb Amputation Below Knee
12/25
06/26
NCT05884203: Improving Prosthetic Provision in Rural Communities: Limb Scanning With Caregiver Assistance

Recruiting
N/A
25
US
Caregiver socket, Prosthetist socket
VA Office of Research and Development
Lower Extremity Amputation
04/26
09/26
Lin, Daniel
S1802, NCT03678025: Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Recruiting
3
1273
Europe, US, RoW
Abiraterone, CB 7598, Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Degarelix, FE200486, Firmagon, Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Flutamide, 4'-Nitro-3'-trifluoromethylisobutyranilide, Apimid, Cebatrol, Chimax, Cytomid, Drogenil, Euflex, Eulexine, Flucinom, Flucinome, Flugerel, Fluken, Flulem, FLUT, Fluta-Gry, Flutabene, Flutacan, Flutamex, Flutamin, Flutan, Flutaplex, Fugerel, Grisetin, Niftolide, Oncosal, Profamid, Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, Prostacur, Prostadirex, Prostica, Prostogenat, SCH 13521, Tafenil, Tecnoflut, Testotard, Goserelin Acetate, ZDX, Zoladex, Histrelin Acetate, Supprelin, Vantas, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Nilutamide, Anandron, Nilandron, RU-23908, Orchiectomy, Castration, Male Castration, Male Gonadectomy, orchidectomy, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisonum, Prednitone, Promifen, Servisone, SK-Prednisone, Quality-of-Life Assessment, Quality of Life Assessment, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, irradiation, Radiation, Radiotherapeutics, RADIOTHERAPY, RT, Therapy, Radiation, Radical Prostatectomy, Prostatovesiculectomy, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Decapeptyl, Detryptoreline
SWOG Cancer Research Network, National Cancer Institute (NCI)
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
04/28
10/31
A022102, NCT05677490: MFOLFIRINOX Versus MFOLFOX with or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Recruiting
3
382
US
Fluorouracil, 2,4-Dioxo-5-fluoropyrimidine, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluoro-2,4(1H,3H)-pyrimidinedione,, Leucovorin Calcium, 1492-18-8, 5-Formyl Tetrahydrofolate, Calcium (6S)-Folinate, Calcium Folinate, Oxaliplatin, 1-OHP, Dacotin, Dacplat, ELOXATIN, Irinotecan, Nivolumab, MDX-1106, Opdivo, Magnetic Resonance Imaging, MRI, Computed Tomography, CAT Scan, Computed Axial Tomography, CT Scan, Biospecimen Collection, Questionnaire Administration
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC V8, Clinical Stage III Gastric Cancer AJCC V8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC V8, Clinical Stage IV Esophageal Adenocarcinoma AJCC V8, Clinical Stage IV Gastric Cancer AJCC V8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC V8, Metastatic Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Unresectable Esophageal Adenocarcinoma, Unresectable Gastric Adenocarcinoma, Unresectable Gastroesophageal Junction Adenocarcinoma
11/28
11/28
PARAMMUNE, NCT06203600: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Recruiting
2/3
224
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Questionnaire Administration, Ramucirumab, Anti-VEGFR-2 Fully Human Monoclonal Antibody IMC-1121B, Cyramza, IMC 1121B, IMC-1121B, IMC1121B, LY 3009806, LY-3009806, LY3009806, Monoclonal Antibody HGS-ETR2
National Cancer Institute (NCI)
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Metastatic Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Unresectable Esophageal Adenocarcinoma, Unresectable Gastric Adenocarcinoma, Unresectable Gastroesophageal Junction Adenocarcinoma
10/27
10/27
JANUS, NCT05610163: Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation

Recruiting
2
312
US
Capecitabine, 5-fluorouracil, Leucovorin calcium, Irinotecan, Oxaliplatin, Long Course Chemoradiotherapy, Computed Tomography, Magnetic Resonance Imaging, Sigmoidoscopy, biopsy
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC V8, Stage III Rectal Cancer AJCC V8
09/25
09/32
ELU-FRα-1, NCT05001282: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Terminated
1/2
79
US
ELU001, FA-CDC
Elucida Oncology
Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer
06/24
06/24
PASS, NCT00756665: Prostate Active Surveillance Study

Recruiting
N/A
3000
Canada, US
University of Washington, Canary Foundation, Early Detection Research Network
Prostatic Neoplasms
09/29
09/32
GIFTS, NCT04254133: Genetic Information to Inform Treatment and Screening for Prostate Cancer, Study

Enrolling by invitation
N/A
1360
US
Questionnaire, Questionnaires, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Genetic Testing, Genetic Analysis, Genetic Examination, Genetic Test, Genetic Counseling, Laboratory Biomarker Analysis
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Prostate Carcinoma
08/28
08/28
Montgomery, Bruce
CHOMP, NCT04104893: A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation

Recruiting
2
30
US
Pembrolizumab, Keytruda
VA Office of Research and Development, Merck Sharp & Dohme LLC
Metastatic Castration Resistant Prostate Cancer
03/25
12/25
BRACeD, NCT04038502: Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Recruiting
2
100
US
Carboplatin, Paraplatin, Olaparib, Lynparza
VA Office of Research and Development
Metastatic Castrate Resistant Prostate Cancer, BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, RAD51B, RAD51C, RAD51D, or RAD54L Mutations
08/25
08/25
CaRPET, NCT06610825: Castrate Resistant Prostate Cancer Enhertu Therapy

Not yet recruiting
2
60
NA
Enhertu
Washington D.C. Veterans Affairs Medical Center, Daiichi Sankyo, Cancer Research And Biostatistics, Institute for Clinical Research
Prostate Cancer Metastatic, Prostate Cancer, CRPC
10/27
10/28
Simpson, Tracy
IMPROVE, NCT04486066: An Evaluation of MBSR and CBT for Veterans With Chronic Pain

Completed
N/A
217
US
Mindfulness-Based Stress Reduction, Cognitive Behavioral Therapy for Chronic Pain, Usual Care
VA Office of Research and Development
Chronic Pain, Pain
05/24
09/24
Kearney, David
SHIELD II, NCT04411199 / 2020-003617-36: D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection

Recruiting
3
624
Europe, US, RoW
D-PLEX, Standard of Care (SoC)
PolyPid Ltd.
Surgical Site Infection, Colon Surgery, Abdominal Surgery, Post-Op Infection
03/25
03/25
IMPROVE, NCT04486066: An Evaluation of MBSR and CBT for Veterans With Chronic Pain

Completed
N/A
217
US
Mindfulness-Based Stress Reduction, Cognitive Behavioral Therapy for Chronic Pain, Usual Care
VA Office of Research and Development
Chronic Pain, Pain
05/24
09/24
Hebert, Paul
NCT04518943: Multiphase Optimization Trial of Incentives for Veterans to Encourage Walking

Completed
N/A
100
US
Walking
VA Office of Research and Development
Sedentary Behavior, Exercise, Walking, Motivation, Hypertension, Depression, Body Mass Index
11/23
07/24
Utzschneider, Kristina Marie
NCT03625648: Pentoxifylline in Diabetic Kidney Disease

Recruiting
4
2510
US
Pentoxifylline, Placebo
VA Office of Research and Development
Diabetic Kidney Disease
01/28
07/30
Collins, Margaret P
EQuiP COPD, NCT05718102: Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Recruiting
N/A
4000
US
Population-health management
Seattle Institute for Biomedical and Clinical Research, Patient-Centered Outcomes Research Institute
Pulmonary Disease, Chronic Obstructive
01/27
01/27
Wang, David
NCT05219981: 18F F-AraG-PET Imaging to Evaluate Immunological Response CKI Therapy in Solid Tumors Imaging

Not yet recruiting
2
40
US
Fluorine F 18 Ara-G
Stanford University
Solid Tumor
06/24
06/26
NCT05945823: Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Recruiting
2
66
Europe, US
Futibatinib, TAS-120, Pembrolizumab, MK-3475, KEYTRUDA®, Cisplatin, PLATINOL®, 5-FU, ADRUCIL®, Oxaliplatin, ELOXATIN®, Leucovorin, calcium folinate, folinic acid, WELLCOVORIN®, Levoleucovorin, calcium levofolinate, levofolinic acid, FUSILEV®, Irinotecan
Taiho Oncology, Inc.
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer, Esophageal Adenocarcinoma, Esophageal Squamous Cell Cancer, Siewert Type 1 GEJ Cancer, Pancreatic Cancer
01/25
05/25
NCT04018872: Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Recruiting
2
78
US
Itraconazole
Dallas VA Medical Center
Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma
06/26
09/26
NCT05563766: A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Recruiting
2
78
US
Itraconazole
VA Office of Research and Development, Durham VA Health Care System, VA Palo Alto Health Care System, Portland VA Medical Center, VA Puget Sound Health Care System, Michael E. DeBakey VA Medical Center, VA Boston Healthcare System, North Texas Veterans Healthcare System, VA Ann Arbor Healthcare System
Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma
04/29
06/29
NCT02749513: Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients

Active, not recruiting
1
18
US
Itraconazole
Dallas VA Medical Center
Esophageal Cancer
09/19
10/22
Sangeorzan, Bruce
NCT00391365: Treatment Outcomes for Ankle Arthritis

Active, not recruiting
N/A
368
US
Gait analysis
VA Office of Research and Development, Orthopaedic Associates of Michigan (Grand Rapids, MI), Orthopedic + Fracture Specialists, Portland, OR, Minnesota Orthopedic Sports Medicine Institute Twin Cities Orthopedics (Edina, MN)
Osteoarthritis
08/15
08/24
RB/AFO, NCT03524729: Do Rocker Bottom Shoes and Ankle-Foot Orthoses Reduce Pain and Improve Mobility for Ankle Osteoarthritis Patients

Completed
N/A
11
US
Rocker bottom shoe, Ankle foot orthosis, Standard walking shoe
VA Office of Research and Development
Ankle Osteoarthritis, Healthy Ankles
06/22
06/23
NCT01620541: Comparing Ankle Fusion to Ankle Replacement

Active, not recruiting
N/A
516
US
Ankle Arthrodesis, Ankle Fusion, Ankle Arthroplasty, Total Ankle Replacement
Seattle Institute for Biomedical and Clinical Research, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), University of Washington, Orthopedic + Fracture Specialists, Portland, OR, Minnesota Orthopedic Sports Medicine Institute at Twin Cities Orthopedics, Orthopaedic and Spine Center of the Rockies, Orthopaedic Associates of Michigan, PC
End-stage Ankle Arthritis (ESAA), Osteoarthritis (OA)
05/26
05/27
Dash, Atreya
PASS, NCT00756665: Prostate Active Surveillance Study

Recruiting
N/A
3000
Canada, US
University of Washington, Canary Foundation, Early Detection Research Network
Prostatic Neoplasms
09/29
09/32
Fan, Vincent S
Shade, NCT02825654: Service and Health Among Deployed Veterans

Enrolling by invitation
N/A
6200
US
VA Office of Research and Development, United States Department of Defense, Harvard University
Pulmonary Function
09/26
12/27
Wu, Daniel
SUNRAY-01, NCT06119581: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Recruiting
3
1016
Europe, Canada, Japan, US, RoW
LY3537982, Olomorasib, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed
Eli Lilly and Company, Loxo Oncology, Inc.
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
10/26
10/29
NCT05563766: A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Recruiting
2
78
US
Itraconazole
VA Office of Research and Development, Durham VA Health Care System, VA Palo Alto Health Care System, Portland VA Medical Center, VA Puget Sound Health Care System, Michael E. DeBakey VA Medical Center, VA Boston Healthcare System, North Texas Veterans Healthcare System, VA Ann Arbor Healthcare System
Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma
04/29
06/29
Littman, Alyson
NCT03733054: Understanding Prosthetic Needs and Outcomes in Women Veterans With Amputation

Completed
N/A
324
US
VA Office of Research and Development
Amputation
03/22
12/22
NCT05728411: Effectiveness of Remote Foot Temperature Monitoring

Recruiting
N/A
800
US
Remote foot temperature monitoring system, Enhanced usual care
VA Office of Research and Development
Diabetic Foot
12/26
12/31
Mayer, Cynthia A
NCT04000555: Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)

Terminated
4
26
US
Oral Vancomycin, Placebo
University of South Florida
Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence
06/22
06/22
NCT02965027: Prazosin for Post-Concussive Headaches

Completed
4
89
US
Prazosin, Minipress, Placebo, inactive substance, sugar pill
Seattle Institute for Biomedical and Clinical Research, VA Puget Sound Health Care System, Madigan Army Medical Center
Post-Traumatic Headache
05/23
06/23
NCT00717964: Study of Raltegravir Versus Nucleotide Reverse Transcriptase Inhibitors (NRTIs) as a Backbone in HIV-Infected Subjects Switched From a Stable Boosted Protease Inhibitor (PI) Regimen

Active, not recruiting
3
34
US
Raltegravir, Isentress, current antiretroviral regimen
St. Joseph's Hospital, Florida
HIV Infections
07/11
10/11
NCT02266329: Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin

Completed
1/2
89
US
prazosin hydrochloride, Minipress, placebo, inactive drug; sugar pill; dummy pill
VA Office of Research and Development
Posttraumatic Headache, Combat Disorders, Post Concussion Syndrome, Headache, Mild Traumatic Brain Injury, Posttraumatic Migraine
05/23
09/23
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting
N/A
600
US
No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment
Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research
HIV Infections, Multi-Antiviral Resistance
06/25
12/25
Friedman, Daphne
NCT05008848: Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Recruiting
3
600
US
Smoking Cessation Intervention, Health Promotion and Education, Informational Intervention, Questionnaire Administration
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Cigarette Smoking-Related Carcinoma
06/25
11/25
Benefit VA, NCT06520098: A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Not yet recruiting
2
100
US
Venetoclax, VENCLEXTA, Ibrutinib, Acalabrutinib, Zanubrutinib, IMBRUVICA, CALQUENCE, BRUKINSA
VA Office of Research and Development
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
06/30
12/30
Selinexor, NCT06452446: Telehealth-based Symptom Management for Veterans Treated With

Not yet recruiting
N/A
20
NA
Selinexor, Xpovio
Durham VA Medical Center, Duke University
Multiple Myeloma, Large-cell Lymphoma
07/26
07/28
NCT05334069: Collecting Blood Samples from Patients with and Without Cancer to Evaluate Tests for Early Cancer Detection

Recruiting
N/A
2000
US
Questionnaire Administration, Biospecimen Collection
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ann Arbor Stage I Lymphoma, Ann Arbor Stage II Lymphoma, Ann Arbor Stage III Lymphoma, Ann Arbor Stage IV Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Gastroesophageal Junction Adenocarcinoma, Head and Neck Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Invasive Breast Carcinoma, Kidney Carcinoma, Malignant Hepatobiliary Neoplasm, Malignant Solid Neoplasm, Melanoma, Muscle-Invasive Bladder Carcinoma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma, RISS Stage III Plasma Cell Myeloma, Sarcoma, Stage I Bladder Cancer AJCC V6 and V7, Stage I Breast Cancer AJCC V7, Stage I Colorectal Cancer AJCC V6 and V7, Stage I Esophageal Cancer AJCC V7, Stage I Gastric Cancer AJCC V7, Stage I Lung Cancer AJCC V7, Stage I Ovarian Cancer AJCC V6 and V7, Stage I Pancreatic Cancer AJCC V6 and V7, Stage I Prostate Cancer AJCC V7, Stage I Uterine Corpus Cancer AJCC V7, Stage II Bladder Cancer AJCC V6 and V7, Stage II Breast Cancer AJCC V6 and V7, Stage II Colorectal Cancer AJCC V7, Stage II Esophageal Cancer AJCC V7, Stage II Gastric Cancer AJCC V7, Stage II Lung Cancer AJCC V7, Stage II Ovarian Cancer AJCC V6 and V7, Stage II Pancreatic Cancer AJCC V6 and V7, Stage II Prostate Cancer AJCC V7, Stage II Uterine Corpus Cancer AJCC V7, Stage III Bladder Cancer AJCC V6 and V7, Stage III Breast Cancer AJCC V7, Stage III Colorectal Cancer AJCC V7, Stage III Esophageal Cancer AJCC V7, Stage III Gastric Cancer AJCC V7, Stage III Lung Cancer AJCC V7, Stage III Ovarian Cancer AJCC V6 and V7, Stage III Pancreatic Cancer AJCC V6 and V7, Stage III Prostate Cancer AJCC V7, Stage III Uterine Corpus Cancer AJCC V7, Stage IV Bladder Cancer AJCC V7, Stage IV Breast Cancer AJCC V6 and V7, Stage IV Colorectal Cancer AJCC V7, Stage IV Esophageal Cancer AJCC V7, Stage IV Gastric Cancer AJCC V7, Stage IV Lung Cancer AJCC V7, Stage IV Ovarian Cancer AJCC V6 and V7, Stage IV Pancreatic Cancer AJCC V6 and V7, Stage IV Prostate Cancer AJCC V7, Stage IV Uterine Corpus Cancer AJCC V7, Thyroid Gland Carcinoma
01/26
02/27
Dominitz, Jason A
NCT03796884: Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer

Active, not recruiting
2
230
US
Linaclotide, 851199-59-2, Linzess, [9-L-tyrosine]heat-stable enterotoxin (Escherichia coli)-(6-19)-peptide, L-Tyrosine, L-cysteinyl-L-cysteinyl-L-alpha-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L- asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteiny, cyclic (1->6), (2->10), (5->13)-tris(disulfide), MD-1100, Placebo
Sidney Kimmel Cancer Center at Thomas Jefferson University, United States Department of Defense
Colorectal Adenoma, Stage 0 Colorectal Cancer AJCC v8, Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage IIA Colorectal Cancer AJCC v8, Stage IIB Colorectal Cancer AJCC v8, Stage IIC Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8, Stage IIIC Colorectal Cancer AJCC v8
06/25
06/25
CADeNCE, NCT05888623: Computer Assisted Detection of Neoplasia During Colonoscopy Evaluation

Enrolling by invitation
N/A
200000
US
Computer Assisted Detection, GI Genius Intelligent Endoscopy Module (Medtronic)
VA Puget Sound Health Care System, VA Salt Lake City Health Care System, San Francisco Veterans Affairs Medical Center
Colorectal Neoplasms
09/23
09/24
CONFIRM, NCT01239082 / 2010-019246-11: Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer

Active, not recruiting
N/A
50126
US
Colonoscopy, FIT
VA Office of Research and Development
Colorectal Cancer
12/28
12/28
Crothers, Kristina
ACHIEVE, NCT03856879: High-quality COPD Care for People with Immune Dysfunction Through Proactive E-consults

Active, not recruiting
N/A
270
US
Proactive E-consult
Seattle Institute for Biomedical and Clinical Research, VA Puget Sound Health Care System, Washington D.C. Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, University of Colorado, Denver, VA Greater Los Angeles Healthcare System, Atlanta VA Medical Center, Yale University, VA Connecticut Healthcare System, Corporal Michael J. Crescenz VA Medical Center, Nashville VA Medical Center
COPD, HIV/AIDS
03/25
04/25
WISH, NCT04505371: Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV

Active, not recruiting
N/A
226
US
Wellness Intervention for Smokers with HIV
Seattle Institute for Biomedical and Clinical Research, Kaiser Permanente, University of California, Davis, Fred Hutchinson Cancer Center, US Department of Veterans Affairs
HIV Infections, Smoking, Smoking Cessation
08/25
02/26
LAUREL, NCT04628039: Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs

Recruiting
N/A
476
US
VA Office of Research and Development
COVID-19, Chronic Lung Diseases
10/25
12/25
Leehey, David J
NCT03625648: Pentoxifylline in Diabetic Kidney Disease

Recruiting
4
2510
US
Pentoxifylline, Placebo
VA Office of Research and Development
Diabetic Kidney Disease
01/28
07/30
Storm, Peter R
NCT03532100: Pivot-Flex Foot: Optimal Coupling Ratio Between Transverse and Sagittal-plane Motions Using a Torsionally Adaptive Prosthesis for Individuals With Lower Limb Amputation

Recruiting
N/A
15
US
Torsionally adaptive prosthesis with 0:1 coupling ratio, Torsionally adaptive prosthesis with 1:6 coupling ratio, Torsionally adaptive prosthesis with 1:4 coupling ratio, Torsionally adaptive prosthesis with 1:3 coupling ratio, Torsionally adaptive prosthesis with 1:2 coupling ratio
VA Office of Research and Development
Lower Extremity Amputation
10/24
03/25
IMPROVE, NCT04486066: An Evaluation of MBSR and CBT for Veterans With Chronic Pain

Completed
N/A
217
US
Mindfulness-Based Stress Reduction, Cognitive Behavioral Therapy for Chronic Pain, Usual Care
VA Office of Research and Development
Chronic Pain, Pain
05/24
09/24
Kendall, Diane L
NCT03635554: Translation and Clinical Implementation of a Test of Language and Short-term Memory in Aphasia

Enrolling by invitation
N/A
150
US
Temple University, University of Washington
Aphasia
11/25
11/25
Reger, Greg
NCT04959695: Evaluation of the PE Coach Mobile Application Among Veterans With PTSD

Recruiting
N/A
124
US
PE Coach, Prolonged exposure without PE Coach
VA Office of Research and Development, Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury
Posttraumatic Stress Disorder
06/27
09/27
Thomas, Rachel
NCT05263778: Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study

Not yet recruiting
4
500
US
Bempedoic Acid / Ezetimibe Oral Tablet, Nexlizet, Placebo
Kaiser Permanente, Esperion Therapeutics, Inc.
Cardiovascular Diseases, NSTEMI, STEMI
06/23
12/23
NCT05728411: Effectiveness of Remote Foot Temperature Monitoring

Recruiting
N/A
800
US
Remote foot temperature monitoring system, Enhanced usual care
VA Office of Research and Development
Diabetic Foot
12/26
12/31
Zabetian, Cyrus
C-SAPP, NCT04373317: Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Recruiting
4
358
US
Pimavanserin, Quetiapine
VA Office of Research and Development
Parkinson's Disease Psychosis
10/25
08/26
NCT01558479: The Parkinson's Genetic Research Study

Recruiting
N/A
5000
US
University of Washington
Parkinson's Disease
10/26
10/26
PANUC, NCT01720810: Pacific Northwest Udall Center () Clinical Core

Recruiting
N/A
2000
US
University of Washington
Parkinson Disease, Cognitive Impairment
10/25
10/25
NCT04101968: The GBA Multimodal Study in Parkinson's Disease

Recruiting
N/A
25
Canada, US
PET scan, neuroQWERTY
Pacific Parkinson's Research Centre, University of British Columbia, University of Washington, Oregon Health and Science University, Simon Fraser University, Michael J. Fox Foundation for Parkinson's Research, Silverstein Foundation, Weston Brain Institute
Parkinson Disease, GBA Gene Mutation, Gaucher Disease
12/25
12/25
Bekelman, David
NCT03763032: Psychosocial Intervention in Latino Patients with Advanced Cancer

Completed
N/A
14
US
Counseling
University of Colorado, Denver
Advanced Cancer
11/18
11/18
ADAPT, NCT02713347: Advancing Symptom Alleviation With Palliative Treatment

Completed
N/A
306
US
ADAPT Intervention
VA Office of Research and Development
Heart Failure, Pulmonary Disease, Chronic Obstructive, Emphysema, Pulmonary Fibrosis, Interstitial Lung Disease
12/20
12/21
LSTDI, NCT05001009: Goals of Care Conversations Study

Enrolling by invitation
N/A
72
US
Clinician Implementation Strategy Stage 1: low intensity clinician training, Clinician Implementation Strategy Stage 2: high intensity clinician training, Low patient engagement, PREPARE information and website, High patient engagement, PREPARE information and website and phone call
VA Office of Research and Development
Seriously Ill Patients, Cancer, Heart Failure, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, End-stage Renal Disease, End-stage Liver Disease, Dementia
09/24
09/25
Ledoux, William R
ODRS, NCT02629731: Orthotic Dose Response Study

Completed
N/A
35
US
custom orthoses with varying degrees of hindfoot posting
VA Office of Research and Development, University of Washington
Ankle Osteoarthritis, Flat Foot or Pes Planus
05/22
12/23
Reger, Mark A
Project HOPE, NCT06378541: Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting

Not yet recruiting
N/A
928
US
Virtual Hope Box Enhanced Facilitation, VHB-EF, Enhanced Usual Care, EUC
VA Office of Research and Development
Suicide Prevention, Suicide Attempt, Suicidal Ideation
10/28
10/28
NCT05484297: Increasing Social Connection Through Crisis Caring Contacts: A Pragmatic Trial

Recruiting
N/A
920
US
Crisis Caring Contacts post cards, Control post cards
VA Office of Research and Development
Loneliness
09/25
09/25
Garshick, Eric
BETTER COPD-PH, NCT05937854: Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Recruiting
2
126
US
Tadalafil, Adcirca, Cialis, Placebo
VA Office of Research and Development, VA Boston Healthcare System, Atlanta VA Medical Center, VA Eastern Colorado Health Care System, VA Nebraska Western Iowa Health Care System
Chronic Obstructive Pulmonary Disease, Pulmonary Hypertension, Dyspnea
06/27
12/27
Shade, NCT02825654: Service and Health Among Deployed Veterans

Enrolling by invitation
N/A
6200
US
VA Office of Research and Development, United States Department of Defense, Harvard University
Pulmonary Function
09/26
12/27
Proctor, Susan P
Shade, NCT02825654: Service and Health Among Deployed Veterans

Enrolling by invitation
N/A
6200
US
VA Office of Research and Development, United States Department of Defense, Harvard University
Pulmonary Function
09/26
12/27
Lehavot, Keren
NCT02012907: Evaluation of Web-Based CBT for Women Veterans With PTSD

Not yet recruiting
N/A
100
US
DESTRESS-WV, Phone Support
Department of Veterans Affairs
PTSD
12/18
12/18
 

Download Options